Enveric Biosciences (FRA:SLZ0) Buyback Yield %: -70.60 (As of Jul. 11, 2026)


FRA:SLZ0 Enveric Biosciences Inc FRA:SLZ0
30 GF Score
Price €56.07
! 1 Warning Sign
View Full Analysis

What is Enveric Biosciences Buyback Yield %?

Enveric Biosciences FRA:SLZ0 30 Buyback Yield % is -70.60 as of Jul. 11, 2026. GuruFocus rates FRA:SLZ0 with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 742 Biotechnology companies, Enveric Biosciences ranks worse than 87.74% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Enveric Biosciences's current buyback yield was -70.60%.

Enveric Biosciences Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Enveric Biosciences's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enveric Biosciences Buyback Yield % Chart

Enveric Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -63.25 -488.76 0.00 -97.38 -8.43

Enveric Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -158.35 -159.19 -160.15 -152.55 -109.48

FRA:SLZ0 vs APVO, CNSP, ADIL: Buyback Yield % Comparison

For the Biotechnology subindustry, Enveric Biosciences's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enveric Biosciences Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Enveric Biosciences's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Enveric Biosciences's Buyback Yield % falls into.


FRA:SLZ0
30GF Score
Enveric Biosciences Inc FRA:SLZ0
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enveric Biosciences Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Enveric Biosciences's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 5.022) / 59.54634
=-8.43%

Enveric Biosciences's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 3.455) / 105.86016
=-3.26%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -70.60 mean?
Enveric Biosciences (FRA:SLZ0) has a Buyback Yield % of -70.60 as of Jul. 11, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Enveric Biosciences and its competitors. According to the industry distribution chart, Enveric Biosciences ranks #651 out of 742 companies in the Biotechnology industry, placing it in the top 87.7%.
Is Enveric Biosciences' Buyback Yield % too high?
Enveric Biosciences' current Buyback Yield % is -70.60. Based on the distribution chart, Enveric Biosciences ranks #651 out of 742 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Enveric Biosciences has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Enveric Biosciences' Buyback Yield % compare to APVO and CNSP?
According to the Biotechnology industry distribution chart, Enveric Biosciences ranks #651 out of 742 companies for Buyback Yield %. This places Enveric Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Enveric Biosciences and its competitors. Enveric Biosciences's current Buyback Yield % is -70.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enveric Biosciences stock overvalued right now?
Enveric Biosciences (FRA:SLZ0) has a current Buyback Yield % of -70.60. The current Buyback Yield % is -70.60. Enveric Biosciences' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Enveric Biosciences (FRA:SLZ0), the current Buyback Yield % is -70.60 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enveric Biosciences Business Description

Other Exchanges ENVB:USA
Address 245 First Street, 18th Floor, Riverview II, Cambridge, MA, USA, 02142
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
30GF Score

Get the complete analysis for FRA:SLZ0

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€56.07
Price